DXCM
$DXCM
DexCom, Inc.
Continuous glucose monitoring systems for diabetes management.
HealthcareSubscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
DXCM: CGM Recovery vs Competitive Pressure
Dexcom ($DXCM) sits at an inflection point with a strong analyst consensus but a 30% drawdown from its 52-week high, a new CEO, and Q1 2026 earnings on April 30. This report balances growth potential in CGM adoption against execution and valuation risks.
Apr 6, 2026